Clinical Trial
BeiGene Initiates New Phase 3 Trial of Anti-PD-1 Antibody Tislelizumab Combined with Chemotherapy as First-line Treatment for Patients with Advanced Squamous Non-Small Cell Lung Cancer in China
BeiGene
PR-M08-18-NI-115Aug 30, 2018
Clinical Trials
Xcovery Announces First Cohort of Patients Dosed in a Phase 1/2 Clinical Trial of Vorolanib
Xcovery
PR-M08-18-NI-035Aug 09, 2018